Fluzone and Fluzone High-Dose
STN: BL 103914
Proper Name: Influenza Virus Vaccine
Tradename: Fluzone and Fluzone High-Dose
Manufacturer: Sanofi Vaccines US Inc.
- Fluzone is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.
- Fluzone High-Dose is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.
- July 1, 2026 Approval Letter - Fluzone and Fluzone High-Dose
- July 1, 2025 Approval Letter - Fluzone and Fluzone High-Dose
- April 29, 2025 Approval Letter - Fluzone High-Dose
- July 1, 2024 Approval Letter- Fluzone and Fluzone High-Dose
- July 2, 2019 Approval Letter - Fluzone Quadrivalent and Fluzone High-Dose
- January 23, 2019 Approval Letter - Fluzone High-Dose
- June 29, 2018 Approval Letter- Fluzone
- January 10, 2018 Approval Letter - Fluzone
- July 7, 2017 Approval Letter - Fluzone
- Clinical Review Memorandum - Fluzone High-Dose Quadrivalent
- Toxicology Review - Fluzone High-Dose Quadrivalent
- Statistical Review -Fluzone High-Dose
- Supporting Documents older than three years - Fluzone, Fluzone High-Dose and Fluzone Intradermal